Wiser Advisor Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Sell
4,279
-2
-0% -$2.04K 5.62% 3
2026
Q1
$3.94M Sell
4,281
-52
-1% -$52.7K 4.76% 4
2025
Q4
$4.66M Sell
4,333
-71
-2% -$67.9K 5.33% 4
2025
Q3
$3.36M Buy
4,404
+105
+2% +$78.1K 4.18% 4
2025
Q2
$3.35M Buy
4,299
+77
+2% +$59.8K 5.82% 3
2025
Q1
$3.49M Buy
4,222
+1,710
+68% +$1.42M 5.15% 3
2024
Q4
$1.94M Buy
2,512
+903
+56% +$748K 2.82% 12
2024
Q3
$1.43M Buy
1,609
+128
+9% +$115K 2.13% 17
2024
Q2
$1.34M Buy
1,481
+34
+2% +$27.2K 2.11% 16
2024
Q1
$1.13M Buy
1,447
+1,413
+4,156% +$1.01M 1.77% 21
2023
Q4
$19.8K Buy
+34
New +$19.8K 0.03% 150

Other funds holding LLY

Wiser Advisor Group's LLY Position: Q2 2026 in Review

Wiser Advisor Group reduced its Eli Lilly (LLY) stake by 0.05% in Q2 2026, selling an estimated $2.04K and leaving 4,279 shares worth $5.13M. The position accounts for 5.62% of the portfolio, ranked #3.

Wiser Advisor Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wiser Advisor Group held 4,279 shares of Eli Lilly worth $5.13M as of Q2 2026.
  • Wiser Advisor Group sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 5.62% of Wiser Advisor Group's portfolio in Q2 2026, its #3 holding.
  • Wiser Advisor Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.